Evidence map›Paper›PMID 19688191›Full record

ArticleJournal of molecular neuroscience : MN2010

Glutamate-dopamine crosstalk in the rat prefrontal cortex is modulated by Alpha7 nicotinic receptors and potentiated by PNU-120596.

Phil D Livingstone, Jane A Dickinson, Jayaraman Srinivasan, James N C Kew, Susan Wonnacott

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.Advances in pharmacology (San Diego, Calif.) · 2016
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Neuroinflammation and psychiatric illness.Journal of neuroinflammation · 2013
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Phil D LivingstoneDepartment of Biology & Biochemistry, University of Bath, Bath, BA2 7AY, UK.
Jane A Dickinson
Jayaraman Srinivasan
James N C Kew
Susan Wonnacott
University of Bath · GBGlaxoSmithKline (Netherlands) · NL

Funding

Biotechnology and Biological Sciences Research Council BBS/B/15600
6 · The paper itself

Abstract

The aim of this study was to explore the modulation by alpha7 nicotinic receptors (nAChRs) of dopamine and glutamate release in the rat prefrontal cortex where these receptors are implicated in attentional processes and are therapeutic targets for cognitive deficits. The presence of presynaptic alpha7 nAChRs on glutamate terminals is supported by the ability of the subtype-selective agonist Compound A to evoke [(3)H]D-aspartate release from synaptosomes: This response was potentiated by the selective allosteric potentiator PNU-120596 and blocked by alphabungarotoxin. Compound A also evoked dopamine overflow in the prefrontal cortex in vivo, and this was potentiated by PNU-120596. alpha7 nAChR-evoked [(3)H]dopamine release from tissue prisms in vitro was blocked by antagonists of NMDA and AMPA receptors. These data are consistent with a model in which alpha7 nAChRs present on glutamate terminals increase glutamate release that (1) contributes to presynaptic facilitation and synaptic plasticity and (2) co-ordinately enhances dopamine release from neighbouring boutons.

Indexed as

Acetylcholinealpha7 Nicotinic Acetylcholine ReceptorAnimalsAspartic AcidDopamineExcitatory Amino Acid AntagonistsExtracellular FluidGlutamineIsoxazolesMicrodialysisNeuronal PlasticityNicotinic AgonistsNicotinic AntagonistsPhenylurea CompoundsPrefrontal CortexPresynaptic Terminals1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)ureaAcetylcholinealpha7 Nicotinic Acetylcholine ReceptorAspartic AcidChrna7 protein, ratDopamineExcitatory Amino Acid AntagonistsGlutamineIsoxazolesNicotinic AgonistsNicotinic AntagonistsPhenylurea CompoundsReceptors, Nicotinic

Identifiers

PMID19688191
OpenAlexW2049005941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.